How to Get Kesimpta (Ofatumumab) Covered by Aetna (CVS Health) in Georgia: Complete PA Guide and Appeal Scripts
Quick Answer: Aetna (CVS Health) requires prior authorization for Kesimpta (ofatumumab) with documented relapsing MS diagnosis, neurologist prescription, and evidence of prior DMT failures or contraindications. In Georgia, you have 180 days to appeal internal denials and 60 days for external review through the Georgia Department of Insurance. Start by